Concurrent tamoxifen (TAM) + cyclophosphamide, epirubicin, and fluorouracil (CEF) versus TAM + delayed CEF after six months of endocrine therapy in metastatic breast cancer--a randomized trial from the Danish Breast Cancer Cooperative Group (DBCG)

Acta Oncol. 1996:35 Suppl 5:57. doi: 10.3109/02841869609083970.

Authors

P Pfeiffer¹, C Rose, B Ejlertsen, M Andersson, D Pedersen, H T Mouridsen

Affiliation

¹ Department of Oncology, Odense University Hospital, Denmark.

PMID: 9142967
DOI: 10.3109/02841869609083970

No abstract available

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Breast Neoplasms / drug therapy*
Cyclophosphamide / administration & dosage
Drug Administration Schedule
Epirubicin / administration & dosage
Female
Fluorouracil / administration & dosage
Humans
Neoplasm Metastasis
Tamoxifen / administration & dosage

Substances

Tamoxifen
Epirubicin
Cyclophosphamide
Fluorouracil